Physician profile
Mihail Beckerman
NPI 1598793234
$2,439.29
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,921 · 2020: $146 · 2021: $197 · 2022: $176.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,838.58 | 2019-2022 | |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Si-Bone, INC. | $120.38 | 2021 | |
| Vertiflex, INC. | $109.50 | 2019 | |
| Boston Scientific Corporation | $85.86 | 2022 | |
| Medtronic, INC. | $67.65 | 2021-2022 | |
| Avanos Medical | $20.10 | 2022 | |
| Spr Therapeutics, INC | $16.79 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mihail Beckerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.